Bank of New York Mellon’s Bio-Path Holdings Inc BPTH Stock Holding History
Bought
Maintained
Sold
Other funds holding BPTH
UOTTAIMCU
RCA
LTFS
Bank of New York Mellon's BPTH Position: Q2 2018 in Review
Bank of New York Mellon sold out of Bio-Path Holdings Inc (BPTH) in Q2 2018, closing a stake of 27 shares — an estimated $21K sold.
Bank of New York Mellon first reported a position in BPTH in Q1 2014 and held it in 17 quarters. The position peaked at $968K in Q2 2014. 21 funds tracked by Wall St. Rank hold BPTH as of Q2 2018.
- Bank of New York Mellon reported no remaining Bio-Path Holdings Inc position as of Q2 2018 after selling out during the quarter.
- Bank of New York Mellon sold 27 Bio-Path Holdings Inc shares in Q2 2018, an estimated $21K.
- Bank of New York Mellon first reported a position in Bio-Path Holdings Inc in Q1 2014 and held it in 17 quarters.
- Bank of New York Mellon's Bio-Path Holdings Inc position peaked at $968K in Q2 2014.
- 21 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q2 2018.
Based on Bank of New York Mellon's 13F filing for Q2 2018, filed 6 Aug 2018.